Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
43.98 EUR | -0.50% |
|
-.--% | -.--% |
05-23 | Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... | ![]() |
05-23 | Swiss Market Index Closes Little Changed; Julius Bär Gains | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 4.13B | - | ||
-1.17% | 24.26B | C+ | ||
+15.06% | 8.74B | B | ||
+1.22% | 8.21B | C | ||
-31.14% | 6.87B | B- | ||
+16.30% | 5.29B | B- | ||
-9.24% | 3.79B | B- | ||
-8.91% | 3.34B | B+ | ||
+7.27% | 3.19B | C+ | ||
+7.11% | 3.2B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GALE Stock
- G70 Stock
- Ratings Galenica AG